American Bio Medica Corporation (ABMC)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST
American Bio Medica Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Net Income | 0.85 | -1.41 | -0.46 | -0.8 | -0.68 | -1.03 | Upgrade
|
| Depreciation & Amortization | 0.05 | 0.05 | 0.07 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Other Amortization | - | - | - | 0.02 | 0.11 | 0.13 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.11 | - | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.1 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 0.02 | - | 0.05 | 0.02 | 0.02 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -0 | -0.02 | 0 | -0 | -0.02 | Upgrade
|
| Other Operating Activities | -0.04 | -0.04 | -0.18 | 0.18 | 0.1 | 0.13 | Upgrade
|
| Change in Accounts Receivable | 0.05 | 0.24 | 0.1 | -0.04 | 0.08 | -0.09 | Upgrade
|
| Change in Inventory | 0.08 | 0.11 | 0.09 | 0.12 | 0.11 | 0.32 | Upgrade
|
| Change in Accounts Payable | -0.06 | 0.08 | 0.11 | -0.08 | 0.29 | -0.02 | Upgrade
|
| Change in Other Net Operating Assets | 0.07 | 0.19 | -0.48 | -0.02 | -0.06 | 0.25 | Upgrade
|
| Operating Cash Flow | -1.12 | -0.77 | -0.67 | -0.48 | 0.06 | -0.22 | Upgrade
|
| Capital Expenditures | - | - | - | -0 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.02 | Upgrade
|
| Investing Cash Flow | 0.25 | - | - | -0 | - | -0.02 | Upgrade
|
| Short-Term Debt Issued | - | 0.9 | 2.76 | 4.41 | 3.84 | 4.22 | Upgrade
|
| Long-Term Debt Issued | - | 0.96 | 0.08 | 0.08 | 0.09 | 0.06 | Upgrade
|
| Total Debt Issued | 1.64 | 1.86 | 2.83 | 4.48 | 3.92 | 4.28 | Upgrade
|
| Short-Term Debt Repaid | - | -1.08 | -2.22 | -4.06 | -4 | -4.16 | Upgrade
|
| Long-Term Debt Repaid | - | -0.09 | -0.03 | -0.04 | -0.09 | - | Upgrade
|
| Total Debt Repaid | -0.72 | -1.17 | -2.24 | -4.1 | -4.09 | -4.16 | Upgrade
|
| Net Debt Issued (Repaid) | 0.92 | 0.69 | 0.59 | 0.38 | -0.17 | 0.12 | Upgrade
|
| Issuance of Common Stock | - | - | 0.1 | 0.2 | - | 0.2 | Upgrade
|
| Financing Cash Flow | 0.92 | 0.69 | 0.69 | 0.58 | -0.17 | 0.32 | Upgrade
|
| Net Cash Flow | 0.05 | -0.08 | 0.02 | 0.09 | -0.11 | 0.08 | Upgrade
|
| Free Cash Flow | -1.12 | -0.77 | -0.67 | -0.49 | 0.06 | -0.22 | Upgrade
|
| Free Cash Flow Margin | -153.99% | -84.12% | -30.34% | -11.74% | 1.59% | -5.68% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.01 | 0.00 | -0.01 | Upgrade
|
| Cash Interest Paid | 0.18 | 0.18 | 0.19 | 0.15 | 0.16 | 0.16 | Upgrade
|
| Cash Income Tax Paid | 0.04 | 0.04 | 0 | 0 | - | 0 | Upgrade
|
| Levered Free Cash Flow | -0.83 | -0.31 | -0.96 | -0.18 | 0.14 | 0.11 | Upgrade
|
| Unlevered Free Cash Flow | -0.73 | -0.19 | -0.83 | -0.09 | 0.2 | 0.16 | Upgrade
|
| Change in Net Working Capital | 0.01 | -0.58 | 0.17 | -0.17 | -0.47 | -0.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.